J O Schroder
Overview
Explore the profile of J O Schroder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schulte D, Paulsen K, Turk K, Brandt B, Freitag-Wolf S, Hagen I, et al.
Nutr Metab Cardiovasc Dis
. 2018 Aug;
28(11):1100-1105.
PMID: 30143407
Background And Aims: Chronic inflammatory diseases (CID) are associated with a profound increase in cardiovascular (CV) risk resulting in reduced life expectancy. However, LDL-cholesterol is reported to be low in...
2.
Juptner M, Flachsbart F, Caliebe A, Lieb W, Schreiber S, Zeuner R, et al.
Lupus
. 2017 Oct;
27(4):600-609.
PMID: 29050534
Objectives Low copy numbers and deletion of complement C4 genes are potent risk factors for systemic lupus erythematosus (SLE). However, it is not known whether this genetic association affects the...
3.
Hubner R, Zeuner R, Schroder J
Internist (Berl)
. 2017 May;
41(12):1412-1415.
PMID: 28550332
No abstract available.
4.
Juptner M, Zeuner R, Schreiber S, Laudes M, Schroder J
Lupus
. 2014 Feb;
23(4):428-30.
PMID: 24482144
This case report describes two female lupus patients who both received biological treatment with tocilizumab and with belimumab. The disease course was remarkably similar in both cases. Tocilizumab resulted in...
5.
Schroder J, Zeuner R, Bewig B, Both M
Z Rheumatol
. 2012 Jun;
71(4):278-87.
PMID: 22699216
Pulmonary emergencies in rheumatic diseases are rare, potentially life-threatening conditions that occur either as a manifestation of the disease itself or as an adverse event of immunosuppressive treatment. Diffuse alveolar...
6.
Moosig F, Damm F, Knorr-Spahr A, Ritgen M, Zeuner R, Kneba M, et al.
Clin Exp Immunol
. 2006 Nov;
146(3):409-16.
PMID: 17100759
Inherited C1q deficiency is associated strongly with the development of systemic lupus erythematosus (SLE). The aim of our study was to evaluate the ability of monocytes from SLE patients without...
7.
Klapper W, Moosig F, Sotnikova A, Qian W, Schroder J, Parwaresch R
Ann Rheum Dis
. 2004 Nov;
63(12):1681-3.
PMID: 15547095
Objective: To evaluate telomerase activity as a marker of lymphocyte proliferation in systemic lupus erythematosus (SLE). Methods: CD19+, CD4+, and CD8+ lymphocytes were isolated from the peripheral blood of nine...
8.
Lamprecht P, Moosig F, Adam-Klages S, Mrowietz U, Csernok E, Kirrstetter M, et al.
Ann Rheum Dis
. 2004 Oct;
63(11):1518-20.
PMID: 15479908
Case Reports: A 66 year old female patient had relapsing fever and non-suppurative panniculitis suggestive of enigmatic "Weber-Christian disease" (WCD). Antineutrophil cytoplasmic antibodies with specificity for human leucocyte elastase (HLE-ANCA)...
9.
Moosig F, Zeuner R, Renk C, Schroder J
Lupus
. 2004 Oct;
13(8):605-6.
PMID: 15462491
There is evidence from animal and human studies that IL-1 might play an important role in the development and maintainence of inflammation in systemic lupus erythemathosus (SLE). We hypothesized that,...
10.
Moosig F, Czech N, Mehl C, Henze E, Zeuner R, Kneba M, et al.
Ann Rheum Dis
. 2004 Jun;
63(7):870-3.
PMID: 15194587
Objective: To quantify 18-fluorodeoxyglucose (FDG) accumulation in large vessels in patients with polymyalgia rheumatica by positron emission tomography (PET), and to compare these data with serological markers of inflammation. Methods:...